InvestorsHub Logo
Followers 28
Posts 4372
Boards Moderated 1
Alias Born 09/22/2006

Re: None

Monday, 02/19/2024 4:03:51 PM

Monday, February 19, 2024 4:03:51 PM

Post# of 8694
FWIW, today on mainstream daytime TV I saw a well-produced ad for Vyvgart and Vyvgart Hytrulo. I rarely turn on the television and almost never see daytime TV, so I don't know how often this spot runs but it was good to see.
On the other hand, if you look at the Halozyme.com website, you would be confused to find out that this drug is still in phase 3 and not listed among the commercially launched products.
You would also be falsely led to believe that subcu efgartigimod is still being developed for thrombocytopenia and pemphigus vulgaris despite these trials having been terminated for failure to meet endpoints.
At least Argenx is on the ball. Glad Helen is not running that company or any of our other partners.

The more you know, the less you don't know.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News